ArticleBMC public health2025
"You can do this at home and people won't find out": a qualitative exploration of women's experiences with the use of medication abortion drugs received directly from pharmacies in Nepal.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn Nepal, over two-thirds of abortion seekers use medication abortion drugs to terminate their pregnancies. However, fewer than half of all abortions occur in government-approved facilities. Although the government of Nepal discourages pharmacy sale of medication abortion drugs without a prescription, pharmacies account for one-fifth of all abortion services in the country. We conducted a qualitative study to gain insight into why women obtain medication abortion care through pharmacies and document their experiences.
methodsUsing a multi-modal recruitment strategy, we interviewed 25 women from three populous districts of Nepal's Koshi Province who had used medication abortion drugs purchased from pharmacies within the previous two years. We used ATLAS.ti 24 to manage our data and analyzed interviews for content and themes using inductive and deductive techniques.
resultsWe found that confidentiality, convenience, cost, and connection led women to obtain medication abortion care from pharmacies. Many of our participants were unaware of the free services offered by government health centers or reported that they avoided these facilities due to privacy concerns and/or the perceived need for accompaniment. Most of our participants received the mifepristone/misoprostol regimen from pharmacies without a prescription but were charged more than the mandated maximum retail price. Although pharmacy workers informed women on how to administer the medications, they provided little or no counselling on side effects, complications, post-abortion contraception, or additional medications such as those for pain management. Despite confidence in their decision to terminate their pregnancies and their ability to self-diagnose the pregnancy, take the pills, and confirm completion of the abortion, some of our participants found the abortion process challenging due to insufficient counselling, variable costs, and the lack of pain medications.
conclusionWomen seek pharmacy-based medication abortion services for various reasons, including barriers within the health system that limit access to public sector abortion sites. Strengthening the role of pharmacies as medication abortion providers is crucial as they are in a position to enhance women's agency by providing accurate information, medically sound services, and appropriate referrals. Establishing policies and guidelines to formally integrate pharmacies as safe medication abortion sites in Nepal appears warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.